Skip to content
Pharmaceutical Consulting, Regulatory Services, CEE
Services for drug and medical device companies
  • HOME
  • ABOUT US
  • PRESENCE BY COUNTRY
  • NEWS & ANALYTICS
  • CONTACT
enquiries@groveonline.com
  • HOME
  • ABOUT US
  • PRESENCE BY COUNTRY
  • NEWS & ANALYTICS
  • CONTACT

Monthly Archives: August 2016

You are here:
  1. Home
  2. 2016
  3. August

EMA Releases List of Medical Events for Pharmacovigilance Monitoring

export, Featured, UncategorizedBy wpusername919622. August 2016

The European Medicines Agency (EMA) has released a list of standardized terms describing medical events it says will be used by the agency and other European regulators to identify suspected adverse events. EMA says the list will assist it and other regulators to prioritize the review of suspected adverse events that “deserve special attention, irrespective…

Hungary spends 745 M EUR on hospital developments in Budapest

export, Featured, UncategorizedBy wpusername919610. August 2016

The government has allocated around 235 billion forints (EUR 754.6m) towards the first phase of hospital development and upgrades planned in the capital which are scheduled to begin at the beginning of next year at the latest, the government commissioner for hospital developments told daily Magyar Idők on Saturday. Most of the funds, around 185…

Medicinessafety monitoring : StatusandProspects

export, Featured, UncategorizedBy wpusername91963. August 2016

Based on the WHO definition pharmacovigilance is “scientific research related to the detection, assessment, understanding and prevention of adverse reactions or any other problems associated with medical drugs.” The ” thalidomide tragedy” caused creation of pharmacovigilance in EU. During just a few years of existing on the drug market, thalidomide became the cause of birth…

Go to Top